Our hypothesis is based on the concept that the function of Tau is decisively pathological in dementias, and we hypothesize a FKBP 52 induced change quantitatively and/or qualitatively, which could be profitable to the patients (Figure 7) treated as early as possible after the beginning of the disease. The gene discussed is MAPT; the disease is dementia.